医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2013年
31期
177-177,178
,共2页
米非司酮%利凡诺%中孕引产
米非司酮%利凡諾%中孕引產
미비사동%리범낙%중잉인산
Mifepristone%induced%labor on middle pregnancy
目的:探讨米非司酮在中期妊娠利凡诺引产中的临床效果方法将100例孕16-26周自愿终止妊娠的孕妇随机分为观察组和对照组,对照组50例采用常规利凡诺100m g羊膜腔内注射,观察组在利凡诺100m g羊膜腔内注射后,第二天早、晚空腹给予米非司酮25m g口服。结果观察组产程发动早、总产程时间短、产后出血少、产道损伤少,与对照组相比,差异有统计学意义。结论利凡诺联合米非司酮应用于中期引产方法安全,效果可靠,能缩短引产时间,预防产后出血。
目的:探討米非司酮在中期妊娠利凡諾引產中的臨床效果方法將100例孕16-26週自願終止妊娠的孕婦隨機分為觀察組和對照組,對照組50例採用常規利凡諾100m g羊膜腔內註射,觀察組在利凡諾100m g羊膜腔內註射後,第二天早、晚空腹給予米非司酮25m g口服。結果觀察組產程髮動早、總產程時間短、產後齣血少、產道損傷少,與對照組相比,差異有統計學意義。結論利凡諾聯閤米非司酮應用于中期引產方法安全,效果可靠,能縮短引產時間,預防產後齣血。
목적:탐토미비사동재중기임신리범낙인산중적림상효과방법장100례잉16-26주자원종지임신적잉부수궤분위관찰조화대조조,대조조50례채용상규리범낙100m g양막강내주사,관찰조재리범낙100m g양막강내주사후,제이천조、만공복급여미비사동25m g구복。결과관찰조산정발동조、총산정시간단、산후출혈소、산도손상소,여대조조상비,차이유통계학의의。결론리범낙연합미비사동응용우중기인산방법안전,효과가고,능축단인산시간,예방산후출혈。
Observation: To discuss the clinical effect of induced labor on middle pregnancy by combining using of Rivanol and Mifepristone. Methods:100 cases of 16-26 weeks pregnant women who voluntarily terminate pregnancy were randomly divided into the observation group and the control group. In control group 50 cases use 100mg amniotic cavity injection of rivanol. In observation group, after injection of 100mg rivanol into amniotic cavity, the cases take 25mg mifepristone on an empty stomach in the second morning and evening. Results:compared with the control group, the observation group labor time is shorter, with earlier onset of labor, less postpartum hemorrhage and minor birth canal injury. The difference is significant in statistics. Conclusions:In the induction of labor in second trimester, using Rivanol combined with Mifepristone is safer and reliable. It can shorten induction time and prevent postpartum hemorrhage.